159 related articles for article (PubMed ID: 3896470)
21. Insulin treatment in cancer cachexia: effects on survival, metabolism, and physical functioning.
Lundholm K; Körner U; Gunnebo L; Sixt-Ammilon P; Fouladiun M; Daneryd P; Bosaeus I
Clin Cancer Res; 2007 May; 13(9):2699-706. PubMed ID: 17473202
[TBL] [Abstract][Full Text] [Related]
22. Metabolic response to insulin and glucose infusions in starved tumor-bearing rats.
Rofe AM; Bourgeois CS; Bais R; Conyers RA
Cancer Res; 1989 Nov; 49(21):5949-53. PubMed ID: 2676152
[TBL] [Abstract][Full Text] [Related]
23. β-hydroxy-β-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia.
Aversa Z; Bonetto A; Costelli P; Minero VG; Penna F; Baccino FM; Lucia S; Rossi Fanelli F; Muscaritoli M
Int J Oncol; 2011 Mar; 38(3):713-20. PubMed ID: 21184031
[TBL] [Abstract][Full Text] [Related]
24. Provision of rhIGF-I/IGFBP-3 complex attenuated development of cancer cachexia in an experimental tumor model.
Wang W; Iresjö BM; Karlsson L; Svanberg E
Clin Nutr; 2000 Apr; 19(2):127-32. PubMed ID: 10867731
[TBL] [Abstract][Full Text] [Related]
25. Glucose metabolism and the percentage of glucose derived from alanine: response to exogenous glucose infusion in tumor-bearing and non-tumor-bearing rats.
Arbeit JM; Burt ME; Rubinstein LV; Gorschboth CM; Brennan MF
Cancer Res; 1982 Dec; 42(12):4936-42. PubMed ID: 7139597
[TBL] [Abstract][Full Text] [Related]
26. Effects of increased beta 2-agonist dose in tumor-bearing animals.
Stallion A; Foley-Nelson T; Chance WT; Fischer JE
Nutr Cancer; 1993; 20(3):251-60. PubMed ID: 7906412
[TBL] [Abstract][Full Text] [Related]
27. Development of altered taste preferences in tumor-bearing rats.
Smith BK; Barker K; Schork MA; Kluger MJ
Appetite; 1994 Dec; 23(3):219-30. PubMed ID: 7726541
[TBL] [Abstract][Full Text] [Related]
28. Effects of indomethacin, cytokines, and cyclosporin A on tumor growth and the subsequent development of cancer cachexia.
Gelin J; Andersson C; Lundholm K
Cancer Res; 1991 Feb; 51(3):880-5. PubMed ID: 1988128
[TBL] [Abstract][Full Text] [Related]
29. Growth hormone administration preserves lean body mass in sarcoma-bearing rats treated with doxorubicin.
Ng B; Wolf RF; Weksler B; Brennan MF; Burt M
Cancer Res; 1993 Nov; 53(22):5483-6. PubMed ID: 8221688
[TBL] [Abstract][Full Text] [Related]
30. Glucose disposal and gluconeogenesis from alanine in tumor-bearing Fischer 344 rats.
Lowry SF; Foster DM; Norton JA; Berman M; Brennan MF
J Natl Cancer Inst; 1981 Apr; 66(4):653-8. PubMed ID: 6939912
[TBL] [Abstract][Full Text] [Related]
31. [Cytokines in experimental cancer cachexia].
Niu Q; Li T; Liu A
Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):382-4. PubMed ID: 11810767
[TBL] [Abstract][Full Text] [Related]
32. Characterization of a transplantable adenocarcinoma of the mouse colon producing cachexia in recipient animals.
Bibby MC; Double JA; Ali SA; Fearon KC; Brennan RA; Tisdale MJ
J Natl Cancer Inst; 1987 Mar; 78(3):539-46. PubMed ID: 3546909
[TBL] [Abstract][Full Text] [Related]
33. Insulin reverses ammonia-induced anorexia and experimental cancer anorexia.
Chance WT; Thomas I; Fischer JE
Nutr Cancer; 1994; 21(3):213-22. PubMed ID: 7521032
[TBL] [Abstract][Full Text] [Related]
34. Effect of cancer on the in vivo energy state of rat liver and skeletal muscle.
Schneeberger AL; Thompson RT; Driedger AA; Finley RJ; Inculet RI
Cancer Res; 1989 Mar; 49(5):1160-4. PubMed ID: 2917347
[TBL] [Abstract][Full Text] [Related]
35. Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care--correlations with food intake, metabolism, exercise capacity, and hormones.
Fouladiun M; Körner U; Bosaeus I; Daneryd P; Hyltander A; Lundholm KG
Cancer; 2005 May; 103(10):2189-98. PubMed ID: 15822132
[TBL] [Abstract][Full Text] [Related]
36. Effect of cerebrocrast on body and organ weights, food and water intake, and urine output of normal rats.
Briede J; Stivrina M; Stoldere D; Vigante B; Duburs G
Cell Biochem Funct; 2008 Dec; 26(8):908-15. PubMed ID: 19039818
[TBL] [Abstract][Full Text] [Related]
37. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
38. Fish oil supplementation in F1 generation associated with naproxen, clenbuterol, and insulin administration reduce tumor growth and cachexia in Walker 256 tumor-bearing rats.
Pinto JA; Folador A; Bonato SJ; Aikawa J; Yamazaki RK; Pizato N; Facin M; Grohs H; de Oliveira HH; Naliwaiko K; Ferraz AC; Nishiyama A; Fernandez R; Curi R; Fernandes LC
J Nutr Biochem; 2004 Jun; 15(6):358-65. PubMed ID: 15157942
[TBL] [Abstract][Full Text] [Related]
39. Anticatabolic effect of the beta 2-agonist cimaterol in vivo in tumor-bearing animals.
Stallion A; Foley-Nelson T; Chance WT; James JH; Fischer JE
J Surg Res; 1995 Sep; 59(3):387-92. PubMed ID: 7643598
[TBL] [Abstract][Full Text] [Related]
40. Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement.
Barber MD; McMillan DC; Preston T; Ross JA; Fearon KC
Clin Sci (Lond); 2000 Apr; 98(4):389-99. PubMed ID: 10731472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
